163
Participants
Start Date
November 4, 2019
Primary Completion Date
June 23, 2026
Study Completion Date
July 23, 2026
dabrafenib
dabrafenib oral, twice daily
trametinib
trametinib oral, once daily
Novartis Investigative Site, Brussels
Novartis Investigative Site, Darlinghurst
Novartis Investigative Site, Parkville
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Ctr, New York
Novartis Investigative Site, Torino
Novartis Investigative Site, Berlin
Novartis Investigative Site, Marseille
Novartis Investigative Site, Genova
Novartis Investigative Site, Stockholm
Childrens National Hospital, Washington D.C.
Novartis Investigative Site, Milan
Novartis Investigative Site, Hamburg
Johns Hopkins Hospital, Baltimore
Novartis Investigative Site, Madrid
Novartis Investigative Site, Brest
Nicklaus Childrens Hospital, Miami
Novartis Investigative Site, Tampere
Novartis Investigative Site, Rennes
Novartis Investigative Site, Rennes
St Jude Childrens Research Hospital, Memphis
Novartis Investigative Site, Essen
Novartis Investigative Site, Valencia
Novartis Investigative Site, Florence
Novartis Investigative Site, Cologne
Novartis Investigative Site, Vandœuvre-lès-Nancy
University of Minnesota, Minneapolis
Novartis Investigative Site, Paris
Texas Childrens Hospital, Houston
Phoenix Children s Hospital, Phoenix
Novartis Investigative Site, Augsburg
Novartis Investigative Site, Villejuif
Novartis Investigative Site, Moscow
Novartis Investigative Site, Petah Tikva
Indiana Uni School of Medicine, Indianapolis
Dana Farber Cancer Institute, Boston
Cinn Children Hosp Medical Center, Cincinnati
Novartis Investigative Site, CABA
Novartis Investigative Site, Barretos
Novartis Investigative Site, São Paulo
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Toronto
Novartis Investigative Site, Montreal
Novartis Investigative Site, Brno
Novartis Investigative Site, Prague
Novartis Investigative Site, Copenhagen
Novartis Investigative Site, Roma
Novartis Investigative Site, Setagaya-ku
Novartis Investigative Site, Osaka
Novartis Investigative Site, Utrecht
Novartis Investigative Site, Sutton
Novartis Investigative Site, Liverpool
Novartis Investigative Site, London
Novartis Investigative Site, London
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY